Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of MLD10 in the Prevention of Migraine Headache in Adults

NCT02322333 is registered in ClinicalTrials.gov with Pharmalyte Solutions LLC as lead sponsor.

NCT NCT02322333
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02322333 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of MLD10 in the Prevention of Migraine Headache in Adults
Lead sponsor
Pharmalyte Solutions LLC
Phase
Phase 2/3
Overall status
Completed
Start date
March 31, 2015
Completion date
June 30, 2017
Enrollment
157 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

migraine